Fig. 3.
Fig. 3. Survival estimates by bleeding intensity in autologous patients. Median survival in minor bleeding was 17.3 months, 13.5 months in moderate, and 5.2 months in severe bleeding. Significant differences were found between NBLD and minor bleeding (P = .0004) and between moderate versus severe bleeding (P = .023). Minor versus moderate bleeding was not statistically significant (P = .59). NBLD, patients who did not bleed within 100 days after transplantation.

Survival estimates by bleeding intensity in autologous patients. Median survival in minor bleeding was 17.3 months, 13.5 months in moderate, and 5.2 months in severe bleeding. Significant differences were found between NBLD and minor bleeding (P = .0004) and between moderate versus severe bleeding (P = .023). Minor versus moderate bleeding was not statistically significant (P = .59). NBLD, patients who did not bleed within 100 days after transplantation.

Close Modal

or Create an Account

Close Modal
Close Modal